ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1376	National Cancer Institute	Html	en	Cervical Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of cervical cancer.	Obstet Gynecol 0.632265 Ib-IIa cervical cancer 0.622159 cervical carcinoma 0.7714 Invasive cervical cancer 0.634596 cervical lesion 0.589978 cell cervical cancer 0.622655 Radiat Oncol Biol 0.629582 cervical carcinoma patients 0.625359 uterine cervix 0.691758 stage IB 0.622493 oncology group study 0.594527 cervical cancer screening 0.639667 pelvic radiation therapy 0.616405 Natl Cancer Inst 0.715673 early-stage cervical carcinoma 0.617419 cervical cancer 0.919863 advanced cervical carcinoma 0.650637 human papillomavirus infection 0.632755 radical surgery 0.591536 Gynecologic Oncology Group 0.647439 Gynecol Oncol 0.719059 stage cervical cancer 0.656488 human papillomavirus 0.762889 radiation therapy 0.621545 et al. 0.77758	early-stage cervical cancer 0.645908 IB cervical carcinoma 0.685888 advanced cervical cancer 0.71286 cervical cancer patients 0.639703 PUBMED Abstract 0.66552 high-risk cervical cancer 0.623567 Recurrent cervical cancer 0.622873 primary cervical cancer 0.62989 abnormal cervical cancer 0.630972 cervical cancer risk 0.6957 Abstract 0.771164 Clin Oncol 0.627188 invasive cervical carcinoma 0.622845 forecasts cervical cancer 0.63215 Oncol Biol Phys 0.631517 Cervical Cancer Meta-Analysis 0.620594 cervical intraepithelial neoplasia 0.750465 I/II cervical cancer 0.623038 HPV infection 0.611536 squamous cervical carcinoma 0.629261 squamous intraepithelial lesions 0.632419 IIA cervical carcinomas 0.590932 cervical cytologic specimens 0.615306 Wright TC Jr 0.598346	CLICK HERE
1445	National Cancer Institute	Html	en	Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)–Health Professional Version	Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.	Oral Mucositis section 0.646528 oral lesions 0.713241 permanent oral complications 0.655143 especially oral mucositis 0.68535 hematopoietic stem cell 0.672562 severe oral mucositis 0.704955 normal oral function. 0.655722 oral infection 0.648431 oral anatomic structures 0.655446 cancer therapy 0.661822 oral pain 0.661419 oral tissues 0.687688 oral management 0.671998 oral mucositis 0.976928 acute oral complications 0.672602 oral complications 0.869367 comprehensive oral care 0.65304 cancer patients 0.684573 oral manifestations 0.663979 Poor oral health 0.644837 oral health 0.672192 local oral infections 0.645116 oral mucosal inflammation 0.655414 necessary oral care 0.650666 oral mucositis index 0.679834	severe oral morbidity 0.658041 item oral mucositis 0.6536 oral mucosa 0.692735 oral care 0.722741 oral mucosal changes 0.646052 oral mucositis guidelines 0.662614 radiation-induced oral mucositis 0.65347 oral mucosal tissues 0.663688 Severe oral toxicities 0.662231 ulcerative oral mucositis 0.758526 chemotherapy-induced oral mucositis 0.687692 common oral complications 0.674757 oral mucosal healing 0.660629 comprehensive oral hygiene 0.655656 oral hygiene 0.74644 oral status 0.661747 oral mucosal integrity 0.669711 nonmedicated oral care 0.646962 acute oral GVHD 0.644918 oral mucosal toxicity 0.664745 oral toxicities 0.662473 oral cavity 0.705394 cancer 0.687828 oral disease 0.662382	CLICK HERE
1549	National Cancer Institute	Html	en	Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®)–Patient Version	Brain and spinal cord tumors may be benign (not cancer) or malignant (cancer). Both types cause signs or symptoms and need treatment. Get information about the many kinds of brain and spinal cord tumors, signs and symptoms, tests to diagnose, and treatment in this expert-reviewed summary.	PDQ Childhood Brain 0.257478 cancer treatment 0.297382 spinal column 0.245566 body 0.252077 PDQ cancer information 0.277635 spinal cord tumor 0.378418 clinical trials 0.370146 health care providers 0.249776 Pediatric Treatment Editorial 0.244163 cancer information summary 0.261575 clinical trial 0.273191 Nervous System Tumors 0.243367 High-grade spinal cord 0.281934 recurrent childhood brain 0.283273 newly diagnosed brain 0.237604 NCI PDQ cancer 0.242529 tests 0.251387 brain stem 0.243824 Metastatic tumors 0.243822 Treatment Editorial Board 0.245992 childhood cancer 0.271461 Cord Tumors Treatment 0.28928 General Information section 0.242596 treatment 0.384234 childhood spinal cord 0.316653	cancer cells 0.347188 standard treatment 0.240256 tumor risk group 0.274387 childhood brain 0.596751 spinal tap 0.246398 signs 0.239529 Benign brain tumors 0.275877 treatment clinical trials 0.238797 National Cancer Institute 0.261551 tumor cells 0.240778 Low-grade spinal cord 0.282176 effects cancer treatment 0.24403 new treatment 0.262653 types 0.237657 childhood cancer information 0.249646 childhood brain tumors 0.325204 PDQ summary 0.248201 tumor marker test 0.242818 Spinal cord nerves 0.295114 Malignant brain tumors 0.275792 cancer 0.437578 information 0.284357 spinal cord tumors 0.945242 brain stem controls 0.239043	CLICK HERE
1747	National Cancer Institute	Html	en	Asbestos Exposure and Cancer Risk	A fact sheet about asbestos, asbestos-related diseases, and who to contact for more information.	Asbestos Ombudsman 0.460839 EPA state asbestos 0.434096 U.S. Consumer Product 0.316535 longer exposure time 0.297627 previous exposure 0.27831 asbestos textiles 0.432289 asbestos causes 0.436856 U.S. Department 0.329349 children’s exposure 0.28171 lung cancer 0.280063 asbestos programs 0.405413 asbestos minerals 0.467011 asbestos removal workers 0.468852 Asbestos School Hazard 0.419561 health care providers 0.290173 asbestos-related diseases 0.348349 health hazards 0.295432 human health effects 0.27966 asbestos exposure increase 0.500132 asbestos mines 0.425258 serpentine asbestos 0.481061 asbestos mining 0.432341 Asbestos page 0.442685 Federal agency 0.290215	Environmental Protection Agency 0.377868 OSHA’s Asbestos 0.42031 health effects 0.305637 Preventing Asbestos Exposure 0.47948 Product Safety Commission 0.317357 asbestos 0.915525 asbestos fibers 0.648932 asbestos exposure 0.842565 U.S. Environmental Protection 0.377874 heavier exposure 0.277348 Occupational Safety 0.288197 exposure history 0.275525 asbestos products 0.436695 amphibole asbestos 0.479754 Asbestos Hazard Emergency 0.41964 asbestos-related disease 0.298672 tiny asbestos fibers 0.468171 Health Administration 0.283037 occupational asbestos exposure 0.500171 Consumer Product Safety 0.316531 health 0.344549 Chrysotile asbestos 0.460267 information 0.278169 risk 0.275773	CLICK HERE
1871	National Cancer Institute	Html	es	Tratamiento del carcinoma de sitio primario desconocido (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del carcinoma de sitio primario desconocido.	cáncer epitelial versus 0.404134 Greco FA 0.432795 unknown primary tumours 0.414817 cisplatin-based combination chemotherapy 0.404363 unknown primary site 0.721557 Pavlidis N 0.405224 Breast carcinoma presenting 0.411406 unknown primary origin 0.450607 Hainsworth JD 0.442528 Metastatic malignant melanoma 0.405856 Cancer Res 0.404192 Radiat Oncol Biol 0.414855 neuroendocrine carcinoma 0.415368 Natl Cancer Inst 0.417117 poorly differentiated 0.438667 Melanoma from unknown 0.410685 serous papillary carcinoma 0.405287 patients with 0.456873 gene expression profiling 0.404698 unknown primary carcinoma 0.451216 carcinoma nasofaríngeo 0.409399 poorly differentiated carcinoma 0.41977 cervical lymph 0.404293 patients with unknown 0.4336 Rodriguez E 0.405003	presenting as axillary 0.404521 metastases from unknown 0.428245 Unknown primary melanoma 0.416245 Abbruzzese MC 0.404845 Curr Probl Cancer 0.404442 primary neoplasm 0.406005 or undiscovered primary 0.406863 from unknown primary 0.455678 primary tumor site 0.417993 Surg Oncol 0.405079 PDQ Tratamiento 0.416061 Intern Med 0.413673 nasopharyngeal carcinoma 0.405469 Clin Oncol 0.44391 Johnson DH 0.404766 unknown primary 0.993061 Oncol Biol Phys 0.415244 with unknown primary 0.46599 metastatic adenocarcinomas 0.408539 unknown primary tumor 0.442645 germ cell tumors 0.405207 carcinoma presenting as 0.411228 occult primary carcinoma 0.410287 cancer incidence 0.406991	CLICK HERE
1877	National Cancer Institute	Html	es	Tratamiento del linfoma primario del sistema nervioso central (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del linfoma primario del sistema nervioso central.	lymphoma collaborative group 0.221499 non-aids primary 0.214603 system lymphoma after 0.212927 cerebral non-Hodgkin lymphoma 0.210841 or intraocular lymphoma 0.212565 Lymphoma Study Group 0.224227 high-dose chemotherapy with 0.225593 International Extranodal Lymphoma 0.221958 intraocular lymphoma 0.239499 with primary cns 0.254535 Primary Brain Tumor 0.210419 high-dose chemotherapy 0.225677 Radiat Oncol Biol 0.211148 Lymphoma Group 0.219295 syndrome-related lymphoma 0.210481 intensive chemotherapy 0.210023 primary cerebral lymphomas 0.210038 central nervous system 0.60114 Extranodal Lymphoma Study 0.223831 patients with primary 0.244525 International Primary Central 0.210485 Ferreri AJ 0.218398 chemotherapy followed 0.215362 chemotherapy with 0.231706 international primary cns 0.215425	Non-AIDS Primary CNS 0.213926 patient with primary 0.21103 primary cns non-Hodgkin 0.214388 primary cns lymphoma 0.988429 recurrent primary cns 0.221546 diagnosed primary cns 0.280123 quimioterapia sistémica 0.213366 System Lymphoma Collaborative 0.212953 Martus P 0.225523 chemotherapy with autologous 0.216514 as primary 0.210335 Primary intraocular lymphoma 0.221058 primary central nervous 0.665308 radiation therapy oncology 0.22435 primary brain 0.216414 Clin Oncol 0.417434 sistema nervioso central 0.287075 Oncol Biol Phys 0.21138 international primary 0.216816 Lymphoma Group Phase 0.212503 non-hodgkin's lymphoma 0.246332 nervous system lymphoma 0.742769 newly diagnosed primary 0.264174 therapy oncology group 0.22259	CLICK HERE
3461	National Cancer Institute	Html	es	Temas sobre terapias integrales, alternativas y complementarias (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos de información sobre las terapias integrales, alternativas y complementarias para personas con cáncer.	llamada lactobacillus acidophilus 0.320398 Sun’s Soup 0.3376 Flor Essence 0.384105 NCI Best Case 0.324965 Selected Vegetables 0.574814 sección suplementos 0.322686 vitamina d 0.319364 vitamina c 0.341075 sustancias químicas llamadas 0.324421 Unidos Selected Vegetables 0.324471 Instituto Nacional 0.442148 sección pectina 0.32118 Salud Complementaria 0.335148 pacientes náuseas 0.357085 coenzima q10 0.48743 PDQ Fatiga 0.398645 Health Interview Survey 0.325066 Estados Unidos 0.550173 sección complementos 0.349035 sección vitamina 0.346665 cardo mariano 0.387654 sección intervenciones 0.319196 punica granatum l 0.321333 sección intervención 0.343132 Centro Nacional 0.320165	sección ejercicio 0.33994 sección soja 0.320395 sección jengibre 0.320032 Sun's Soup 0.379451 sección té 0.319269 coenzima q10 ayuda 0.329386 hierba sonajero 0.430937 pacientes régimen gonzalez 0.360587 sección granada 0.318618 PDQ Temas 0.374069 salud náuseas 0.319268 pacientes linfedema 0.359299 San Juan 0.409901 sección licopeno 0.323612 sección tratamiento 0.563476 Physician Data Query 0.356925 sistema nervioso central 0.321486 enzimas pancreáticas 0.337252 cáncer renal 0.379726 sección terapia 0.318859 ¿El tratamiento 0.326217 sección selenio 0.319463 medicina complementaria 0.95764 terapia gerson 0.366138	CLICK HERE
15479	National Cancer Institute	Html	en	Intramural Investigators Submitting Data	Find general requirements for intramural investigators submitting genomic data. Different processes may exist based on operational differences in NCI intramural research programs.	dbGaP staff 0.612313 Institutional Certification 0.866347 review process 0.634188 accession number 0.623142 accuracy 0.439647 general requirements 0.674142 Institutional Review Board 0.856814 division 0.480859 Assignment 0.440982 NCI intramural research 0.909946 dbGaP Study Release 0.812896 DSPs 0.462568 initiation 0.444589 submission process 0.630778 Scientific Review 0.648183 contact 0.441788 human subjects 0.63038 studies 0.475426 required fields 0.609497 details 0.440138 expectations 0.502409 3. 0.437685 genomic data 0.866328	DSP 0.443274 data submission formats 0.913248 dbGaP submission 0.646264 study submission information 0.828375 Basic Study Information 0.823319 center 0.480797 operational differences 0.660458 different processes 0.658659 steps 0.441942 QA/QC Data Submission 0.891139 submission portal 0.629655 data generation completion 0.860975 plans 0.439922 IRB 0.460706 Data Generation Completed 0.868892 quality assurance check 0.803588 GPA 0.717674 project proposal 0.64122 programs 0.443042 time 0.4353 send 0.442857 de-identified human specimens 0.860465	CLICK HERE
16380	National Cancer Institute	Html	es	Toxicidad financiera del tratamiento del cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del riesgo de sufrir dificultades financieras durante el tratamiento del cáncer.	among patients with 0.356148 National Health Interview 0.33762 survivors identified through 0.3506 Guy GP Jr 0.797953 Targeted Cancer Therapies 0.346578 seguro médico 0.502578 Cancer Care Outcomes 0.395905 Medical Debt And 0.338028 Care Outcomes Research 0.337105 cancer care 0.484521 Adult Cancer Survivors 0.410356 Ekwueme DU 0.389597 estudio cancer care 0.350705 burden among 0.343127 Health Interview Survey 0.341695 Blough D 0.351854 Natl Cancer Inst 0.34743 cáncer versus 0.347441 Medicare Current Beneficiary 0.347647 cancer survivors 0.793538 Duke Cancer Institute 0.343096 with cancer 0.974917 patients with 0.384813 Medicare beneficiaries with 0.362941 Dowling EC 0.336978	Hardship Associated With 0.350445 United States 0.354013 financial hardship 0.453927 experiences with cancer 0.407883 Financial Hardship Associated 0.350297 Health Aff 0.447932 Care Cancer 0.350503 associated with cancer 0.462553 Debt And Bankruptcy 0.341472 Yabroff KR 0.591176 medical expenditure 0.337994 For Working-Age Cancer 0.400083 out-of-pocket health care 0.387866 Working-Age Cancer Survivors 0.410894 Clin Oncol 0.748582 breast cancer 0.503347 Rectal Cancer 0.343774 Non-elderly Cancer Survivors 0.355648 cáncer problemas 0.341283 financial toxicity 0.423332 patients receiving adjuvant 0.339287 MEPS Experiences with 0.352286 Current Beneficiary Survey 0.336425 expenditure burden 0.396505	CLICK HERE
16812	National Cancer Institute	Html	es	Cartílago (bovino y de tiburón) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de cartílago bovino y de tiburón como tratamiento para personas con cáncer. Nota: la información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	MIA Shark Powder 0.309592 libera productos 0.304775 Centro Nacional 0.308058 New Hampshire Avenue 0.30568 Drug Administration 0.303513 NCI Best Case 0.309322 vía oral 0.453913 datos bibliográficos pubmed 0.30595 células llamadas condrocitos 0.314707 siguientes preguntas 0.30389 numerosos productos 0.303672 cartílago bovino catrix 0.352078 National Cancer Institute 0.306865 siguientes riesgos 0.304822 Instituto Nacional 0.331095 Salud Complementaria 0.311787 Visuals Online 0.304093 complementarias revisa 0.305499	Physician Data Query 0.323561 Estados Unidos 0.439543 PDQ Cartílago 0.345303 siguientes estudios 0.31921 libre uso 0.304173 cartílago bovino 0.858349 página manejo 0.303836 tiburón quizás 0.3125 numerosos estudios 0.308556 ¿El tratamiento 0.308146 tiburón llamada ae-941 0.314557 siguientes datos 0.30538 ¿Los beneficios 0.303518 juntos cam 0.30337 Series Program 0.303472 vasos sanguíneos 0.95448 medicina complementaria 0.461353	CLICK HERE